Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Change in Receivables (2020 - 2025)

Historic Change in Receivables for Neuroone Medical Technologies (NMTC) over the last 6 years, with Q4 2025 value amounting to $1.4 million.

  • Neuroone Medical Technologies' Change in Receivables fell 3627.35% to $1.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $292954.0, marking a year-over-year decrease of 8395.22%. This contributed to the annual value of $1.1 million for FY2025, which is 51605.17% up from last year.
  • Latest data reveals that Neuroone Medical Technologies reported Change in Receivables of $1.4 million as of Q4 2025, which was down 3627.35% from $1.3 million recorded in Q3 2025.
  • Neuroone Medical Technologies' 5-year Change in Receivables high stood at $2.2 million for Q4 2024, and its period low was -$2.1 million during Q1 2025.
  • In the last 5 years, Neuroone Medical Technologies' Change in Receivables had a median value of $11956.0 in 2022 and averaged $154221.8.
  • As far as peak fluctuations go, Neuroone Medical Technologies' Change in Receivables surged by 89224.66% in 2023, and later tumbled by 1684945.26% in 2025.
  • Neuroone Medical Technologies' Change in Receivables (Quarter) stood at -$23708.0 in 2021, then skyrocketed by 361.86% to $62082.0 in 2022, then skyrocketed by 775.29% to $543399.0 in 2023, then soared by 303.44% to $2.2 million in 2024, then tumbled by 36.27% to $1.4 million in 2025.
  • Its Change in Receivables stands at $1.4 million for Q4 2025, versus $1.3 million for Q3 2025 and -$318780.0 for Q2 2025.